Trends in reperfusion strategies, door-to-needle and door-to-balloon times, and in-hospital mortality among patients with ST-segment elevation myocardial infarction enrolled in the National Registry of Myocardial Infarction from 1990 to 2006

This publication has 45 references indexed in Scilit:

• Strategies for Reducing the Door-to-Balloon Time in Acute Myocardial Infarction
  New England Journal of Medicine, 2006
• Door-to-drug and door-to-balloon times: Where can we improve? Time to reperfusion therapy in patients with ST-segment elevation myocardial infarction (STEMI)
  American Heart Journal, 2006
• NRMI and current treatment patterns for ST-elevation myocardial infarction
  American Heart Journal, 2004
• ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction
  JACC, 2004
• Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials
  The Lancet, 2003
• Multicentre randomized trial comparing transport to primary angioplasty vs immediate thrombolysis vs combined strategy for patients with acute myocardial infarction presenting to a community hospital without a catheterization laboratory. The PRAGUE Study
  European Heart Journal, 2000
• The Prehospital Electrocardiogram in Acute Myocardial Infarction: Is Its Full Potential Being Realized? fn1fn1The National Registry of Myocardial Infarction 2 is supported by Genentech, Inc., South San Francisco, California.
  JACC, 1997
• Emergency Department: Rapid Identification and Treatment of Patients With Acute Myocardial Infarction—National Heart Attack Alert Program Coordinating Committee
  Annals of Emergency Medicine, 1994
• A Prospective Randomized Clinical Trial of Intracoronary Streptokinase versus Coronary Angioplasty for Acute Myocardial Infarction
  New England Journal of Medicine, 1986
• The Thrombolysis in Myocardial Infarction (TIMI) Trial
  New England Journal of Medicine, 1985